Related Experiment Videos
Social anxiety disorder under scrutiny
1Department of Psychiatry and Behavioral Science, Duke University Medical Center, Durham, North Carolina 27710, USA.
Depression and Anxiety
|June 30, 2000
Summary
Social anxiety disorder, a chronic condition, has multiple causes including genetics and experiences. Selective serotonin reuptake inhibitors (SSRIs) are recommended as a first-line treatment for social anxiety disorder.
Area of Science:
- Psychiatry
- Clinical Psychology
Background:
- Social anxiety disorder (social phobia) is a chronic and disabling mental health condition.
- Its etiology is multifactorial, involving genetic, familial, experiential, and cognitive factors.
Purpose of the Study:
- To review the etiology and diagnostic considerations for social anxiety disorder.
- To provide a comprehensive overview of current psychosocial and pharmacotherapeutic treatment options.
Main Methods:
- Literature review of studies on social anxiety disorder.
- Examination of diagnostic criteria and differential diagnosis.
- Analysis of treatment efficacy for psychosocial and pharmacologic interventions.
Main Results:
- Social anxiety disorder arises from a complex interplay of factors.
- Accurate diagnosis requires differentiating it from other anxiety disorders.
- Psychosocial and pharmacologic treatments show promise, with SSRIs recommended as first-line therapy.
Conclusions:
- Effective management of social anxiety disorder involves understanding its etiology and accurate diagnosis.
- Selective serotonin reuptake inhibitors (SSRIs) are a key pharmacotherapeutic option, with paroxetine being the only licensed SSRI for this condition.